Anzeige
Mehr »
Login
Samstag, 19.09.2020 Börsentäglich über 12.000 News von 646 internationalen Medien
Warum Anleger jetzt noch schnell 100% verdienen können! Absolute Depot-Booster-Aktie!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Xconomy

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
09.07.NFlection Looks to Erase NF1 Tumors With Drug That Only Goes Skin Deep
09.07.VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs
09.07.Biogen Alzheimer's Drug in FDA's Court Following Completion of Filing
08.07.Foghorn Therapeutics Inks Chromatin-Targeting Cancer Deal with Merck
07.07.Novavax Gets $1.6B in Operation Warp Speed Funding for COVID-19 Vaccine
07.07.Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs
07.07.PacBio CEO, CFO Plan Retirements and More People on the Move
06.07.On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO
06.07.Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases
06.07.The 2020 National Xconomy Awards Expands, Goes Virtual & Reopens Nomination Period
03.07.MEI Pharma, Helsinn Scuttle Cancer Drug Trial After Miss on Efficacy
02.07.Moderna: Speed of COVID 19 Vaccine Hinges On Enrolling Right Patients
02.07.Data Quantity, Complexity Drives Use of AI in Drug Discovery and Testing
02.07.Annexon Adds On $100M to Advance Antibodies to Treat Neurodegeneration
02.07.BioNTech's mRNA COVID-19 Vaccine Shows Early Signs of Sparking Immunity
01.07.Amylyx Adds $30M to Press On With Neuro Drug for ALS, Alzheimer's
01.07.Bolt Bio Adds $93.5M to Move Ahead Immune-Stimulating Cancer Drugs
01.07.Chiesi Licenses Bioasis Tech to Tackle Brain Symptoms of Rare Diseases
01.07.Ultragenyx Pharma Wins FDA's First Drug Nod for Rare Metabolic Disorder
30.06.Code for Cures: Life Sciences Thrives on San Francisco's Software Heritage
30.06.Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
30.06.Roche Gets FDA OK for Injectable Version of Breast Cancer Drug
30.06.FDA Says "No" to Intercept Pharma's NASH Drug, Asks for More Data
30.06.FDA Again Dings Heron's Opioid Alternative Over "Nonclinical Issues"
29.06.New Xconomy Special Report: Biopharma and Tech Innovators Summer 2020